New York, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The global subdermal contraceptive implants market size is slated to expand at ~9% CAGR between 2024 and 2036. The market is poised to garner a revenue of ...

“Marketresearch.biz reports that the Subdermal Contraceptive Implants Market presents growth opportunities through expanding awareness campaigns and continuous technological advancements, catering to ...

Vivani Medical, Inc. (NASDAQ:VANI), on Wednesday, released preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic weight management in obese and overweight ...